Suppr超能文献

促进结石排出:坦索罗辛与地塞米松联合药物治疗对肾绞痛患者的疗效

Enhancing stone expulsion: The efficacy of combined medical therapy with tamsulosin and dexamethasone in renal colic patients.

作者信息

Kazemi Reza, Shahrashoub Mohammad, Javid Amir, Saberi Narjes, Ghasemi Pouria, Paymannejad Saina

机构信息

Isfahan Kidney Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Res Med Sci. 2025 Jan 30;30:7. doi: 10.4103/jrms.jrms_258_24. eCollection 2025.

Abstract

BACKGROUND

Ureteral stones are a common aspect of daily urologic practice, affecting 10%-15% of people worldwide over their lifetime. This study aimed to assess the efficacy of combined medical expulsive therapy (MET) with intravenous dexamethasone and oral tamsulosin compared to tamsulosin alone in the frequency and duration of distal ureteral stone expulsion.

MATERIALS AND METHODS

This prospective, double-blind, randomized controlled trial with 1:1 balanced randomization was conducted from September 2022 to March 2023 at Al-Zahra Hospital, a tertiary care facility affiliated with Isfahan University of Medical Sciences. Of 213 patients admitted to our center with acute renal colic, 134 had distal ureteral stones and were assessed. Among them, 105 patients were eligible and included in the trial and were randomly assigned into the intervention group ( = 52) and control group ( = 53). Data from four patients in the case group were omitted from the analysis due to the drop-out from the study.

RESULTS

Mean initial stone size was 6.5 ± 1.2 mm in the intervention, and 6.3 ± 1.0 mm in the control groups, which was not statistically significant ( = 0.488). Gender was comparable between both groups ( = 0.196), whereas the distribution of BMI (27.2 ± 4.0 vs. 29.8 ± 3.9 kg/m, = 0.001) and age (41.5 ± 12.9 vs. 47.9 ± 16.2 years, = 0.031) was not in balance. In total, 43 patients had expelled the stone by the end of the 2 weeks, resulting in an overall expulsion rate of 42.5%. Specifically, 28 (58.3%) patients in the intervention group and 15 (28.3%) patients in the control group had expelled the stone, a difference that was statistically significant ( = 0.002). The time to stone expulsion did not exhibit a significant difference between the intervention and control groups (9.8 vs. 5.4 days, respectively). However, it is noteworthy that the variability in the time to stone expulsion in the tamsulosin + dexamethasone group was considerably smaller than that in the control group, as indicated by the smaller standard deviation in the former (1.0 vs. 3.8 days, respectively).

CONCLUSION

Adding dexamethasone to standard MET with tamsulosin for distal ureterolithiasis appears to increase the stone expulsion rate, although it did not significantly shorten the expulsion time.

摘要

背景

输尿管结石是日常泌尿外科诊疗中的常见病症,全球10%-15%的人在其一生中会受到影响。本研究旨在评估静脉注射地塞米松联合口服坦索罗辛的联合药物排石疗法(MET)与单独使用坦索罗辛相比,在远端输尿管结石排出频率和持续时间方面的疗效。

材料与方法

本前瞻性、双盲、随机对照试验采用1:1均衡随机化,于2022年9月至2023年3月在伊斯法罕医科大学附属的三级医疗设施阿尔-扎赫拉医院进行。在我院因急性肾绞痛入院的213例患者中,134例有远端输尿管结石并接受评估。其中,105例患者符合条件并纳入试验,随机分为干预组(n = 52)和对照组(n = 53)。由于退出研究,病例组4例患者的数据被排除在分析之外。

结果

干预组初始结石平均大小为6.5±1.2mm,对照组为6.3±1.0mm,差异无统计学意义(P = 0.488)。两组性别可比(P = 0.196),而体重指数分布(分别为27.2±4.0与29.8±3.9kg/m²,P = 0.001)和年龄(分别为41.5±12.9与47.9±16.2岁,P = 0.031)不均衡。两周结束时,共有43例患者排出结石,总体排出率为42.5%。具体而言,干预组28例(58.3%)患者和对照组15例(28.3%)患者排出结石,差异有统计学意义(P = 0.002)。干预组和对照组结石排出时间无显著差异(分别为9.8天和5.4天)。然而,值得注意的是,坦索罗辛+地塞米松组结石排出时间的变异性明显小于对照组,前者标准差较小(分别为1.0天和3.8天)。

结论

对于远端输尿管结石,在标准MET中添加地塞米松联合坦索罗辛似乎可提高结石排出率,尽管并未显著缩短排出时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdc/11974596/3741a9a0eb99/JRMS-30-7-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验